| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34858440_HAS_TOPIC_C0001738> <https://research.tib.eu/covid-19/entity/34858440_HAS_TOPIC_C0018736> <https://research.tib.eu/covid-19/entity/34858440_HAS_TOPIC_C0019693> <https://research.tib.eu/covid-19/entity/34858440_HAS_TOPIC_C0019699> <https://research.tib.eu/covid-19/entity/34858440_HAS_TOPIC_C0039215> <https://research.tib.eu/covid-19/entity/34858440_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34858440_HAS_TOPIC_C0275524> <https://research.tib.eu/covid-19/entity/34858440_HAS_TOPIC_C0442886> <https://research.tib.eu/covid-19/entity/34858440_HAS_TOPIC_C1135929> <https://research.tib.eu/covid-19/entity/34858440_HAS_TOPIC_C4505456> <https://research.tib.eu/covid-19/entity/34858440_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34858440_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/34858440_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Academy of Medical Sciences, Malawi University of Science and Technology (MUST), Thyolo, Malawi.\', \'Centre for Immunology and Vaccinology, Department of Infectious Disease, Imperial College London, London, United Kingdom.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Liu_Michael_K_P> <https://research.tib.eu/covid-19/entity/Mandala_Wilson_Lewis>
?:doi	<https://research.tib.eu/covid-19/entity/10.3389/fimmu.2021.797117>
?:doi	10.3389/fimmu.2021.797117
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t> <https://research.tib.eu/covid-19/entity/Review>
?:journal	Frontiers in immunology
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34858440>
?:pmid	<https://research.tib.eu/covid-19/entity/34858440>
?:pmid	34858440
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	2.803
?:rankingScore_hIndex	69
?:title	SARS-CoV-2 and HIV-1: Should HIV-1-Infected Individuals in Sub-Saharan Africa Be Considered a Priority Group for the COVID-19 Vaccines?
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/34858440>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/34858440>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all